# Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing Immunotherapy or Oral Challenges

> **NCT06445374** · PHASE1 · COMPLETED · sponsor: **Dr. George Luciuk** · enrollment: 21 (actual)

## Conditions studied

- Hypersensitivity
- Anaphylaxis

## Interventions

- **DRUG:** Inhaled Epinephrine

## Key facts

- **NCT ID:** NCT06445374
- **Lead sponsor:** Dr. George Luciuk
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-15
- **Primary completion:** 2025-04-08
- **Final completion:** 2025-04-08
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2025-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06445374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06445374, "Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing Immunotherapy or Oral Challenges". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06445374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*